NASDAQ: ABOSAcumen Pharmaceuticals Inc Stock Ownership - Who owns Acumen Pharmaceuticals?
Insider buying vs selling
Have Acumen Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Derrell Porter | Director | 2026-06-17 | 13,040 | $2.33 | $30.32kSell |
| Derrell Porter | Director | 2026-06-17 | 13,040 | $1.07 | $13.95kBuy |
| Derrell Porter | Director | 2026-06-16 | 12,800 | $2.33 | $29.77kSell |
| Derrell Porter | Director | 2026-06-15 | 6,460 | $2.35 | $15.15kSell |
| Derrell Porter | Director | 2026-06-15 | 6,460 | $1.07 | $6.91kBuy |
| Nathan B. Fountain | Director | 2026-06-09 | 6,400 | $2.23 | $14.27kSell |
| Ra Capital Management LP | Director | 2026-03-16 | 6,060,606 | $3.30 | $20.00MBuy |
| Derek M. Meisner | Chief Legal Officer Corp Sec | 2026-03-06 | 2,090 | $1.85 | $3.87kBuy |
| Derek M. Meisner | Chief Legal Officer Corp Sec | 2026-03-06 | 2,090 | $3.26 | $6.81kSell |
| Derek M. Meisner | Chief Legal Officer Corp Sec | 2026-02-27 | 9,406 | $1.85 | $17.40kBuy |
ABOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ABOS insiders and whales buy or sell their stock.
ABOS Shareholders
What type of owners hold Acumen Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Robert D. Hardie | 5.34% | 3,859,141 | $11.15M | Insider |
| Sands Capital Ventures Discovery Fund III LP | 4.73% | 3,417,075 | $9.88M | Insider |
| Daniel Joseph Oconnell | 1.22% | 881,275 | $2.55M | Insider |
| Paul B. Manning | 1.03% | 747,694 | $2.16M | Insider |
| Ra Capital Management LP | 0.81% | 588,850 | $1.70M | Insider |
| John A. Stalfort Iii | 0.49% | 352,219 | $1.02M | Insider |
| Matt Zuga | 0.42% | 304,924 | $881.23k | Insider |
| Eric Siemers | 0.35% | 255,371 | $738.02k | Insider |
| James J. Doherty | 0.31% | 220,900 | $638.40k | Insider |
| Russell Barton | 0.28% | 205,092 | $592.72k | Insider |
ABOS vs Biotech Stocks
Acumen Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.